Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582543 · ClinicalTrials.gov registry record · NA
MRI/MRSI in Risk Assessment of Prostate Cancer Patients
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 357
- Enrollment target
NCT00582543: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00582543 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 357 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582543, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 357 participants
- Enrollment target
Study Summary
The purpose of this study is to see if magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) can tell which patients with prostate cancer are at a low risk for their cancer growing and spreading. Magnetic resonance methods use magnets and radio waves to take pictures of body structure (MRI) and to measure amounts of important chemicals within the body (MRSI). This study will look at the structural and chemical properties of prostates before undergoing treatment. Hopefully, doctors will be able to use this method before making treatment decisions for patients with newly diagnosed cancer of the prostate. This study will continue our work to assess the value of MRI/MRSI in addressing what is currently one of the greatest clinical challenges in the management of prostate cancer: the identification of low-risk organ-confined prostate cancer that can be managed expectantly with deferred treatment.
Interventions
- OTHER eMRI/MRSI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 357 participants |
| Start Date | 2005-10 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582543
The ClinicalTrials.gov registry entry for NCT00582543 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 357 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which eMRI/MRSI is the first listed.
NCT00582543 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00582543 about?
NCT00582543 is a clinical study titled "MRI/MRSI in Risk Assessment of Prostate Cancer Patients". The purpose of this study is to see if magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) can tell which patients with prostate cancer are at a low risk for their cancer growing and spreading. Magnetic resonance methods use magnets and radio waves to take pictures o...
What is the current status of trial NCT00582543?
This trial is currently completed. It is a NA study. The enrollment target is 357 participants. The study started on 2005-10. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00582543?
The interventions under investigation include: eMRI/MRSI (OTHER).
Who is sponsoring clinical trial NCT00582543?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.